Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Randomized, Double-blind Study Comparing Patient Comfort and Safety Between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Peripheral Arteriography

NCT01475097 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT01475097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01475097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Randomized, Double-blind Study Comparing Patient Comfort and Safety Between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Peripheral Arteriography
Lead sponsor
GE Healthcare
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
February 28, 2013
Enrollment
255 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug safety